MSD is committed to improving the health and quality of life of Australians by developing innovative, high quality medicines. Working alongside our parent company, Merck, we strive to stay at the forefront of discovery, undertaking research to find new and better ways of treating a broad range of conditions and diseases.
We are entering an exciting period with a strong product pipeline that targets a broad range of diseases. And we're looking ahead to the next generation of healthcare by using new techniques and technologies.
Therapeutic Areas
We focus our research on several key therapeutic areas, including:
In the Pipeline
From preclinical development to Phase III clinical trials, our passion for advancing health through science is evident in the breadth and depth of our pipeline.